Three million kronor for research on mast cells in asthma

Gunnar Pejler at Uppsala University has received three million kronor from Hjärt-Lungfonden to investigate how old drugs can be used against asthma.

Gunnar Pejler, professor of immunology at Uppsala University, will now deepen his work on drugs that can cause mast cells to break down. The goal is to prevent asthma attacks by stopping inflammation before it reaches the airways.

– We have already seen that certain existing drugs can cause mast cells to break down, which can prevent asthma attacks and ultimately save lives, says Pejler.

Asthma is one of Sweden's most common chronic diseases and affects both children and adults. The research aims to provide more knowledge about how mast cells affect other cells in the lungs.

Jannice Andersson, who has lived with asthma since her teens, takes medication six to eight times a day. She hopes the new research can make daily life easier for people with the disease.

Mga Kaugnay na Artikulo

Illustration of a German woman achieving complete remission from three autoimmune diseases via groundbreaking CAR-T therapy, symbolizing hope and medical triumph.
Larawang ginawa ng AI

CAR-T therapy achieves complete remission of three autoimmune diseases in German woman

Iniulat ng AI Larawang ginawa ng AI

A 47-year-old woman bedridden with autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid syndrome has achieved complete remission after CAR-T cell therapy at University Hospital Erlangen in Germany. Treated by Fabian Müller after nine failed therapies, she recovered rapidly and remains healthy over a year later without medication—the first simultaneous treatment of multiple autoimmune diseases with this method.

A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.

Iniulat ng AI

Researchers at Uppsala University are launching a new treatment study to help young adults who have had cancer address issues related to sexuality and fertility. Around 40 participants aged 18-39 are involved in a 12-week internet-based program. The study is expected to include a total of about 250 people.

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

Iniulat ng AI

The ambulance helicopter in Mora has saved lives across Dalarna for ten years, from forests to remote areas. Police officer Crister Nelefelt survived a cardiac arrest thanks to the team in 2022. Costs are rising, but the service is deemed indispensable.

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan